TY - JOUR
T1 - Phospholipids modulate superoxide and nitric oxide production by lipopolysaccharide and phorbol 12-myristate-13-acetate-activated microglia
AU - Hashioka, Sadayuki
AU - Han, Youn Hee
AU - Fujii, Shunsuke
AU - Kato, Takahiro
AU - Monji, Akira
AU - Utsumi, Hideo
AU - Sawada, Makoto
AU - Nakanishi, Hiroshi
AU - Kanba, Shigenobu
N1 - Funding Information:
This study was supported by a grant from Inogashira Hospital (SH). We thank Prof. Yukihiro Shoyama and Dr. Satoshi Morimoto, Department of Plant Resources Regulation, Graduate School of Pharmaceutical Sciences, Kyushu University, for technical advice about preparing liposomes.
PY - 2007/2
Y1 - 2007/2
N2 - Microglial activation and inflammatory processes have been implicated in the pathogenesis of a number of neurodegenerative disorders. Recently, peroxynitrite (ONOO-), the reaction product of superoxide ({radical dot}O2-) and nitric oxide (NO) both of which can be generated by activated microglia, has been demonstrated to act as a major mediator in the neurotoxicity induced by activated microglia. On the other hand, phospholipids such as phosphatidylserine (PS) and phosphatidylcholine (PC) have been reported to modulate the immune function of phagocytes. We therefore evaluated the effects of liposomes which comprise both PS and PC (PS/PC liposomes) or PC only (PC liposomes) regarding the production of both {radical dot}O2- and NO by lipopolysaccharide (LPS)/phorbol 12-myristate-13-acetate (PMA)-activated microglia using electron spin resonance (ESR) spin trap technique with a DEPMPO and Griess reaction, respectively. Pretreatment with PS/PC liposomes or PC liposomes considerably inhibited the signal intensity of {radical dot}O2- adduct associated with LPS/PMA-activated microglia in a dose-dependent manner. In addition, pretreatment with PS/PC liposomes also significantly reduced LPS/PMA-induced microglial NO production. In contrast, pretreatment with PC liposomes had no effect on the NO production. These results indicate that PS/PC liposomes can inhibit the microglial production of both NO and {radical dot}O2-, and thus presumably prevent a subsequent formation of ONOO-. Therefore, PS/PC liposomes appear to have both neuroprotective and anti-oxidative properties through the inhibition of microglial activation.
AB - Microglial activation and inflammatory processes have been implicated in the pathogenesis of a number of neurodegenerative disorders. Recently, peroxynitrite (ONOO-), the reaction product of superoxide ({radical dot}O2-) and nitric oxide (NO) both of which can be generated by activated microglia, has been demonstrated to act as a major mediator in the neurotoxicity induced by activated microglia. On the other hand, phospholipids such as phosphatidylserine (PS) and phosphatidylcholine (PC) have been reported to modulate the immune function of phagocytes. We therefore evaluated the effects of liposomes which comprise both PS and PC (PS/PC liposomes) or PC only (PC liposomes) regarding the production of both {radical dot}O2- and NO by lipopolysaccharide (LPS)/phorbol 12-myristate-13-acetate (PMA)-activated microglia using electron spin resonance (ESR) spin trap technique with a DEPMPO and Griess reaction, respectively. Pretreatment with PS/PC liposomes or PC liposomes considerably inhibited the signal intensity of {radical dot}O2- adduct associated with LPS/PMA-activated microglia in a dose-dependent manner. In addition, pretreatment with PS/PC liposomes also significantly reduced LPS/PMA-induced microglial NO production. In contrast, pretreatment with PC liposomes had no effect on the NO production. These results indicate that PS/PC liposomes can inhibit the microglial production of both NO and {radical dot}O2-, and thus presumably prevent a subsequent formation of ONOO-. Therefore, PS/PC liposomes appear to have both neuroprotective and anti-oxidative properties through the inhibition of microglial activation.
UR - http://www.scopus.com/inward/record.url?scp=33846642200&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846642200&partnerID=8YFLogxK
U2 - 10.1016/j.neuint.2006.10.006
DO - 10.1016/j.neuint.2006.10.006
M3 - Article
C2 - 17126953
AN - SCOPUS:33846642200
SN - 0197-0186
VL - 50
SP - 499
EP - 506
JO - Neurochemistry International
JF - Neurochemistry International
IS - 3
ER -